210 related articles for article (PubMed ID: 28464560)
1. Matriptase Induction of Metalloproteinase-Dependent Aggrecanolysis In Vitro and In Vivo: Promotion of Osteoarthritic Cartilage Damage by Multiple Mechanisms.
Wilkinson DJ; Wang H; Habgood A; Lamb HK; Thompson P; Hawkins AR; Désilets A; Leduc R; Steinmetzer T; Hammami M; Lee MS; Craik CS; Watson S; Lin H; Milner JM; Rowan AD
Arthritis Rheumatol; 2017 Aug; 69(8):1601-1611. PubMed ID: 28464560
[TBL] [Abstract][Full Text] [Related]
2. Brief Report: JNK-2 Controls Aggrecan Degradation in Murine Articular Cartilage and the Development of Experimental Osteoarthritis.
Ismail HM; Miotla-Zarebska J; Troeberg L; Tang X; Stott B; Yamamoto K; Nagase H; Fosang AJ; Vincent TL; Saklatvala J
Arthritis Rheumatol; 2016 May; 68(5):1165-71. PubMed ID: 26663140
[TBL] [Abstract][Full Text] [Related]
3. Activation of matrix metalloproteinases 2, 9, and 13 by activated protein C in human osteoarthritic cartilage chondrocytes.
Jackson MT; Moradi B; Smith MM; Jackson CJ; Little CB
Arthritis Rheumatol; 2014 Jun; 66(6):1525-36. PubMed ID: 24574263
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Shedding of Low-Density Lipoprotein Receptor-Related Protein 1 Reverses Cartilage Matrix Degradation in Osteoarthritis.
Yamamoto K; Santamaria S; Botkjaer KA; Dudhia J; Troeberg L; Itoh Y; Murphy G; Nagase H
Arthritis Rheumatol; 2017 Jun; 69(6):1246-1256. PubMed ID: 28235248
[TBL] [Abstract][Full Text] [Related]
5. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.
Lark MW; Bayne EK; Flanagan J; Harper CF; Hoerrner LA; Hutchinson NI; Singer II; Donatelli SA; Weidner JR; Williams HR; Mumford RA; Lohmander LS
J Clin Invest; 1997 Jul; 100(1):93-106. PubMed ID: 9202061
[TBL] [Abstract][Full Text] [Related]
6. Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments.
Struglics A; Larsson S; Pratta MA; Kumar S; Lark MW; Lohmander LS
Osteoarthritis Cartilage; 2006 Feb; 14(2):101-13. PubMed ID: 16188468
[TBL] [Abstract][Full Text] [Related]
7. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B
Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
[TBL] [Abstract][Full Text] [Related]
8. MMP proteolysis of the human extracellular matrix protein aggrecan is mainly a process of normal turnover.
Struglics A; Hansson M
Biochem J; 2012 Sep; 446(2):213-23. PubMed ID: 22670872
[TBL] [Abstract][Full Text] [Related]
9. Analysis of ADAMTS4 and MT4-MMP indicates that both are involved in aggrecanolysis in interleukin-1-treated bovine cartilage.
Patwari P; Gao G; Lee JH; Grodzinsky AJ; Sandy JD
Osteoarthritis Cartilage; 2005 Apr; 13(4):269-77. PubMed ID: 15780640
[TBL] [Abstract][Full Text] [Related]
10. Matriptase is a novel initiator of cartilage matrix degradation in osteoarthritis.
Milner JM; Patel A; Davidson RK; Swingler TE; Desilets A; Young DA; Kelso EB; Donell ST; Cawston TE; Clark IM; Ferrell WR; Plevin R; Lockhart JC; Leduc R; Rowan AD
Arthritis Rheum; 2010 Jul; 62(7):1955-66. PubMed ID: 20506309
[TBL] [Abstract][Full Text] [Related]
11. Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5.
Song RH; Tortorella MD; Malfait AM; Alston JT; Yang Z; Arner EC; Griggs DW
Arthritis Rheum; 2007 Feb; 56(2):575-85. PubMed ID: 17265492
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide enhances aggrecan degradation by aggrecanase in response to TNF-alpha but not IL-1beta treatment at a post-transcriptional level in bovine cartilage explants.
Stevens AL; Wheeler CA; Tannenbaum SR; Grodzinsky AJ
Osteoarthritis Cartilage; 2008 Apr; 16(4):489-97. PubMed ID: 17923423
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases and aggrecanases cleave aggrecan in different zones of normal cartilage but colocalize in the development of osteoarthritic lesions in STR/ort mice.
Chambers MG; Cox L; Chong L; Suri N; Cover P; Bayliss MT; Mason RM
Arthritis Rheum; 2001 Jun; 44(6):1455-65. PubMed ID: 11407708
[TBL] [Abstract][Full Text] [Related]
14. Aggrecanolysis and in vitro matrix degradation in the immature bovine meniscus: mechanisms and functional implications.
Wilson CG; Vanderploeg EJ; Zuo F; Sandy JD; Levenston ME
Arthritis Res Ther; 2009; 11(6):R173. PubMed ID: 19919704
[TBL] [Abstract][Full Text] [Related]
15. SOX9 is a regulator of ADAMTSs-induced cartilage degeneration at the early stage of human osteoarthritis.
Zhang Q; Ji Q; Wang X; Kang L; Fu Y; Yin Y; Li Z; Liu Y; Xu X; Wang Y
Osteoarthritis Cartilage; 2015 Dec; 23(12):2259-2268. PubMed ID: 26162802
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1alpha treatment of meniscal explants stimulates the production and release of aggrecanase-generated, GAG-substituted aggrecan products and also the release of pre-formed, aggrecanase-generated G1 and m-calpain-generated G1-G2.
Lemke AK; Sandy JD; Voigt H; Dreier R; Lee JH; Grodzinsky AJ; Mentlein R; Fay J; Schünke M; Kurz B
Cell Tissue Res; 2010 Apr; 340(1):179-88. PubMed ID: 20217136
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilage.
Malfait AM; Liu RQ; Ijiri K; Komiya S; Tortorella MD
J Biol Chem; 2002 Jun; 277(25):22201-8. PubMed ID: 11956193
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase 17 is necessary for cartilage aggrecan degradation in an inflammatory environment.
Clements KM; Flannelly JK; Tart J; Brockbank SM; Wardale J; Freeth J; Parker AE; Newham P
Ann Rheum Dis; 2011 Apr; 70(4):683-9. PubMed ID: 21216815
[TBL] [Abstract][Full Text] [Related]
19. Detection of aggrecanase- and MMP-generated catabolic neoepitopes in the rat iodoacetate model of cartilage degeneration.
Janusz MJ; Little CB; King LE; Hookfin EB; Brown KK; Heitmeyer SA; Caterson B; Poole AR; Taiwo YO
Osteoarthritis Cartilage; 2004 Sep; 12(9):720-8. PubMed ID: 15325638
[TBL] [Abstract][Full Text] [Related]
20. The serine proteinase hepsin is an activator of pro-matrix metalloproteinases: molecular mechanisms and implications for extracellular matrix turnover.
Wilkinson DJ; Desilets A; Lin H; Charlton S; Del Carmen Arques M; Falconer A; Bullock C; Hsu YC; Birchall K; Hawkins A; Thompson P; Ferrell WR; Lockhart J; Plevin R; Zhang Y; Blain E; Lin SW; Leduc R; Milner JM; Rowan AD
Sci Rep; 2017 Dec; 7(1):16693. PubMed ID: 29196708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
